Exosomes and Their Hopeful Advances in Understanding and Treating MG
Laryngeal MG is Best Diagnosed with a Tensilon Test or Pyridostigmine Trial
COVID-19 Infection Raises Myasthenia Gravis Exacerbation Risk
New Treatments Show Promise and MG Market Growth
New therapies and trials show promise in Myasthenia Gravis treatment.
The impact of COVID-19, diagnosis challenges, and ongoing treatment debates.
Emerging digital tools for patient assessment and a deeper understanding of speech-related challenges
Recent advancements in Myasthenia Gravis treatment focus on adolescent patients and the need for individualised care, showcasing promising therapies and the importance of tailored approaches.
Significant research findings on cardiovascular comorbidities, innovative treatment strategies with ravulizumab, management approaches for flares, and holistic self-care practices in myasthenia gravis.
Complexities of immune checkpoint inhibitors in cancer therapy, the role of AI in personalizing Myasthenia Gravis treatment, and the ongoing community efforts to advance treatment options.
